Back to Search Start Over

SARS-CoV-2 accessory proteins involvement in inflammatory and profibrotic processes through IL11 signaling

Authors :
Montoya, María [0000-0002-5703-7360]
Dies López-Ayllón, Blanca
Lucas-Rius, Ana de
Mendoza-García, Laura
García-García, Tránsito
Fernández-Rodríguez, Raúl
Suárez-Cárdenas, José M.
Milhano, Fátima
Corrales, Fernando J.
Redondo, Natalia
Pedrucci, Federica
Zaldívar-López, Sara
Jiménez-Marín, Ángeles
Montoya, María
Garrido, Juan J.
Montoya, María [0000-0002-5703-7360]
Dies López-Ayllón, Blanca
Lucas-Rius, Ana de
Mendoza-García, Laura
García-García, Tránsito
Fernández-Rodríguez, Raúl
Suárez-Cárdenas, José M.
Milhano, Fátima
Corrales, Fernando J.
Redondo, Natalia
Pedrucci, Federica
Zaldívar-López, Sara
Jiménez-Marín, Ángeles
Montoya, María
Garrido, Juan J.
Publication Year :
2023

Abstract

SARS-CoV-2, the cause of the COVID19 pandemic, possesses eleven accessory proteins encoded in its genome. Their roles during infection are still not completely understood. Transcriptomic analysis revealed that both WNT5A and IL11 were significantly up-regulated in A549 cells expressing individual accessory proteins ORF6, ORF8, ORF9b or ORF9c from SARS-CoV-2 (Wuhan-Hu-1 isolate). IL11 signaling-related genes were also differentially expressed. Bioinformatics analysis disclosed that both WNT5A and IL11 were involved in pulmonary fibrosis idiopathic disease. Functional assays confirmed their association with profibrotic cell responses. Subsequently, data comparison with lung cell lines infected with SARS-CoV-2 or lung biopsies from patients with COVID19 evidenced altered gene expression that matched those obtained in this study. Our results show ORF6, ORF8, ORF9b and ORF9c involvement in inflammatory and profibrotic responses. Thus, these accessory proteins could be targeted by new therapies against COVID19 disease.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1380452413
Document Type :
Electronic Resource